Human Formulations

Drotaverine 80 mg + Aceclofenac 100 mg Tablet

Drotaverine 80 mg + Aceclofenac 100 mg Tablet is a tablet formulated with Drotaverine 80 mg + Aceclofenac 100 mg. The active ingredient profile is Drotaverine; Aceclofenac, placing the product in the antispasmodic + nsaid combination category. The formula

TabletsNon-Beta-Lactam Tablets Single Ingredient Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Tablets, Non-Beta-Lactam Tablets
Dosage Form
Tablet
Product Type
Single Ingredient

Available strengths

Drotaverine 80 mg + Aceclofenac 100 mg

Description

Drotaverine 80 mg + Aceclofenac 100 mg Tablet is a tablet formulated with Drotaverine 80 mg + Aceclofenac 100 mg. The active ingredient profile is Drotaverine; Aceclofenac, placing the product in the antispasmodic + nsaid combination category. The formulation combines an antispasmodic component with an analgesic or NSAID component for selected painful spasm-related conditions. The source identifies this item as a tablet product but does not specify a coating or release characteristic on that line. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured